CORRIE SMITH: Open Payments
NPI 1336927953 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,469 in 47 payments from 19 companies in 2025. Trend: 2023 $372 · 2024 $1,825 · 2025 $14,469
Consulting: $13,367Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 4 | $6,786 |
| Janssen Biotech, Inc. | 5 | $6,753 |
| Medtronic, Inc. | 11 | $190 |
| Ferring Pharmaceuticals Inc. | 2 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $145 |
| Sumitomo Pharma America, Inc. | 4 | $82 |
| PFIZER INC. | 3 | $52 |
| UROGEN PHARMA, INC. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Calyxo, Inc. | 1 | $29 |
Products named: ADSTILADRIN, INTERSTIM, Nubeqa, ERLEADA, GEMTESA, XTANDI, AKEEGA, PLUVICTO.
Industry payments across IN — which companies pay providers there.
